ERBB2 and breast carcinoma: In this study, we sought to gain more insight into the effect of LDHC targeting on the transcriptomic landscape of cancer cells, particularly in cancer cells of the basal-like and Her2-enriched breast cancer subtypes, which demonstrate a higher expression of LDHC in corresponding human tumor tissues [10].